Filing Details
- Accession Number:
- 0001140361-17-042137
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-13 16:29:00
- Reporting Period:
- 2017-11-08
- Accepted Time:
- 2017-11-13 16:29:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1685720 | C Kathryn Zoon | 400 Professional Drive Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-11-08 | 2,371 | $38.94 | 20,114 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-11-08 | 371 | $40.84 | 19,743 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- The restricted stock units vest in three equal annual tranches beginning in November 2017.
- The transactions reported in this row were effected pursuant to a Rule 10b5-1 plan adopted by Dr. Zoon.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.25, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.84 to $40.85, inclusive.
Billionaire Hedge Funds
